Skip to menu Skip to content Skip to footer

2020

Journal Article

Blocking immunosuppressive neutrophils deters pY696-EZH2–driven brain metastases

Zhang, Lin, Yao, Jun, Wei, Yongkun, Zhou, Zhifen, Li, Ping, Qu, Jingkun, Badu-Nkansah, Akosua, Yuan, Xiangliang, Huang, Yu-Wen, Fukumura, Kazutaka, Mao, Xizeng, Chang, Wei-Chao, Saunus, Jodi, Lakhani, Sunil, Huse, Jason T., Hung, Mien-Chie and Yu, Dihua (2020). Blocking immunosuppressive neutrophils deters pY696-EZH2–driven brain metastases. Science Translational Medicine, 12 (545) eaaz5387, eaaz5387. doi: 10.1126/scitranslmed.aaz5387

Blocking immunosuppressive neutrophils deters pY696-EZH2–driven brain metastases

2020

Journal Article

Digital spatial profiling application in breast cancer: a user’s perspective

McCart Reed, Amy E., Bennett, James, Kutasovic, Jamie R., Kalaw, Emarene, Ferguson, Kaltin, Yeong, Joe, Simpson, Peter T. and Lakhani, Sunil R. (2020). Digital spatial profiling application in breast cancer: a user’s perspective. Virchows Archiv, 477 (6), 885-890. doi: 10.1007/s00428-020-02821-9

Digital spatial profiling application in breast cancer: a user’s perspective

2020

Journal Article

Novel compound heterozygous variants in NHLRC2 in a patient with FINCA syndrome

Brodsky, Nina N., Boyarchuk, Oksana, Kovalchuk, Tetyana, Hariyan, Tetyana, Rice, Andrew, Ji, Weizhen, Khokha, Mustafa, Lakhani, Saquib and Lucas, Carrie L. (2020). Novel compound heterozygous variants in NHLRC2 in a patient with FINCA syndrome. Journal of Human Genetics, 65 (10), 911-915. doi: 10.1038/s10038-020-0776-0

Novel compound heterozygous variants in NHLRC2 in a patient with FINCA syndrome

2020

Journal Article

Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancer

Adwal, Alaknanda, Kalita-de Croft, Priyakshi, Shakya, Reshma, Lim, Malcolm, Kalaw, Emarene, Taege, Lucinda D., McCart Reed, Amy E., Lakhani, Sunil R., Callen, David F. and Saunus, Jodi M. (2020). Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancer. Life Science Alliance, 3 (7) e201900562, 1-12. doi: 10.26508/lsa.201900562

Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancer

2020

Journal Article

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

Kos, Zuzana, Roblin, Elvire, Kim, Rim S., Michiels, Stefan, Gallas, Brandon D., Chen, Weijie, van de Vijver, Koen K., Goel, Shom, Adams, Sylvia, Demaria, Sandra, Viale, Giuseppe, Nielsen, Torsten O., Badve, Sunil S., Symmans, W. Fraser, Sotiriou, Christos, Rimm, David L., Hewitt, Stephen, Denkert, Carsten, Loibl, Sibylle, Luen, Stephen J., Bartlett, John M. S., Savas, Peter, Pruneri, Giancarlo, Dillon, Deborah A., Cheang, Maggie Chon U., Tutt, Andrew, Hall, Jacqueline A., Kok, Marleen, Horlings, Hugo M. ... International Immuno-Oncology Biomarker Working Group (2020). Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer. NPJ Breast Cancer, 6 (1) 17, 17. doi: 10.1038/s41523-020-0156-0

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

2020

Journal Article

Report on computational assessment of tumor infiltrating lymphocytes from the International Immuno-Oncology Biomarker Working Group

Amgad, Mohamed, Stovgaard, Elisabeth Specht, Balslev, Eva, Thagaard, Jeppe, Chen, Weijie, Dudgeon, Sarah, Sharma, Ashish, Kerner, Jennifer K., Denkert, Carsten, Yuan, Yinyin, AbdulJabbar, Khalid, Wienert, Stephan, Savas, Peter, Voorwerk, Leonie, Beck, Andrew H., Madabhushi, Anant, Hartman, Johan, Sebastian, Manu M., Horlings, Hugo M., Hudeček, Jan, Ciompi, Francesco, Moore, David A., Singh, Rajendra, Roblin, Elvire, Balancin, Marcelo Luiz, Mathieu, Marie-Christine, Lennerz, Jochen K., Kirtani, Pawan, Chen, I-Chun ... International Immuno-Oncology Biomarker Working Group (2020). Report on computational assessment of tumor infiltrating lymphocytes from the International Immuno-Oncology Biomarker Working Group. NPJ Breast Cancer, 6 (1) 16, 16. doi: 10.1038/s41523-020-0154-2

Report on computational assessment of tumor infiltrating lymphocytes from the International Immuno-Oncology Biomarker Working Group

2020

Journal Article

Estrogen and progesterone receptor testing in breast cancer: American society of clinical oncology/college of American pathologists guideline update

Allison, Kimberly H., Hammond, M. Elizabeth H., Dowsett, Mitchell, McKernin, Shannon E., Carey, Lisa A., Fitzgibbons, Patrick L., Hayes, Daniel F., Lakhani, Sunil R., Chavez-MacGregor, Mariana, Perlmutter, Jane, Perou, Charles M., Regan, Meredith M., Rimm, David L., Symmans, W. Fraser, Torlakovic, Emina E., Varella, Leticia, Viale, Giuseppe, Weisberg, Tracey F., McShane, Lisa M. and Wolff, Antonio C. (2020). Estrogen and progesterone receptor testing in breast cancer: American society of clinical oncology/college of American pathologists guideline update. Archives of Pathology and Laboratory Medicine, 144 (5), 545-563. doi: 10.5858/arpa.2019-0904-SA

Estrogen and progesterone receptor testing in breast cancer: American society of clinical oncology/college of American pathologists guideline update

2020

Journal Article

Estrogen and progesterone receptor testing in breast cancer: ASCO/CAP guideline update

Allison, Kimberly H., Hammond, M. Elizabeth H., Dowsett, Mitchell, McKernin, Shannon E., Carey, Lisa A., Fitzgibbons, Patrick L., Hayes, Daniel F., Lakhani, Sunil R., Chavez-MacGregor, Mariana, Perlmutter, Jane, Perou, Charles M., Regan, Meredith M., Rimm, David L., Symmans, W. Fraser, Torlakovic, Emina E., Varella, Leticia, Viale, Giuseppe, Weisberg, Tracey F., McShane, Lisa M. and Wolff, Antonio C. (2020). Estrogen and progesterone receptor testing in breast cancer: ASCO/CAP guideline update. Journal of Clinical Oncology, 38 (12), 1346-1366. doi: 10.1200/JCO.19.02309

Estrogen and progesterone receptor testing in breast cancer: ASCO/CAP guideline update

2020

Journal Article

American registry of pathology expert opinions: The spectrum of lobular carcinoma in situ: Diagnostic features and clinical implications

Schnitt, Stuart J., Brogi, Edi, Chen, Yunn-Yi, King, Tari A. and Lakhani, Sunil R. (2020). American registry of pathology expert opinions: The spectrum of lobular carcinoma in situ: Diagnostic features and clinical implications. Annals of Diagnostic Pathology, 45 151481, 151481. doi: 10.1016/j.anndiagpath.2020.151481

American registry of pathology expert opinions: The spectrum of lobular carcinoma in situ: Diagnostic features and clinical implications

2020

Journal Article

Morphologic and Genomic Heterogeneity in the Evolution and Progression of Breast Cancer

Kutasovic, Jamie R., McCart Reed, Amy E., Sokolova, Anna, Lakhani, Sunil R. and Simpson, Peter T. (2020). Morphologic and Genomic Heterogeneity in the Evolution and Progression of Breast Cancer. Cancers, 12 (4) 848, 848. doi: 10.3390/cancers12040848

Morphologic and Genomic Heterogeneity in the Evolution and Progression of Breast Cancer

2020

Journal Article

Pitfalls and controversies in pathology impacting breast cancer management

Kim, Woo Gyeong, Cummings, Margaret C. and Lakhani, Sunil R. (2020). Pitfalls and controversies in pathology impacting breast cancer management. Expert Review of Anticancer Therapy, 20 (3), 205-219. doi: 10.1080/14737140.2020.1738222

Pitfalls and controversies in pathology impacting breast cancer management

2020

Journal Article

The 2019 WHO classification of tumours of the breast

Hoon Tan, Puay, Ellis, Ian, Allison, Kimberly, Brogi, Edi, Fox, Stephen B., Lakhani, Sunil, Lazar, Alexander J., Morris, Elizabeth A., Sahin, Aysegul, Salgado, Roberto, Sapino, Anna, Sasano, Hironobu, Schnitt, Stuart, Sotiriou, Christos, van Diest, Paul, White, Valerie A., Lokuhetty, Dilani, Cree, Ian A. and WHO Classification of Tumours Editorial Board (2020). The 2019 WHO classification of tumours of the breast. Histopathology, 77 (2) his.14091, 181-185. doi: 10.1111/his.14091

The 2019 WHO classification of tumours of the breast

2020

Journal Article

Pan-cancer analysis of whole genomes

Campbell, Peter J., Getz, Gad, Korbel, Jan O., Stuart, Joshua M., Jennings, Jennifer L., Stein, Lincoln D., Perry, Marc D., Nahal-Bose, Hardeep K., Ouellette, B. F. Francis, Li, Constance H., Rheinbay, Esther, Nielsen, G. Petur, Sgroi, Dennis C., Wu, Chin-Lee, Faquin, William C., Deshpande, Vikram, Boutros, Paul C., Lazar, Alexander J., Hoadley, Katherine A., Louis, David N., Dursi, L. Jonathan, Yung, Christina K., Bailey, Matthew H., Saksena, Gordon, Raine, Keiran M., Buchhalter, Ivo, Kleinheinz, Kortine, Schlesner, Matthias, Zhang, Junjun ... Hamdy, Freddie C. (2020). Pan-cancer analysis of whole genomes. Nature, 578 (7793), 82-93. doi: 10.1038/s41586-020-1969-6

Pan-cancer analysis of whole genomes

2020

Journal Article

Non-coding RNAs underlie genetic predisposition to breast cancer

Moradi Marjaneh, Mahdi, Beesley, Jonathan, O'Mara, Tracy A., Mukhopadhyay, Pamela, Koufariotis, Lambros T., Kazakoff, Stephen, Hussein, Nehal, Fachal, Laura, Bartonicek, Nenad, Hillman, Kristine M., Kaufmann, Susanne, Sivakumaran, Haran, Smart, Chanel E., McCart Reed, Amy E., Ferguson, Kaltin, Saunus, Jodi M., Lakhani, Sunil R., Barnes, Daniel R., Antoniou, Antonis C., Dinger, Marcel E., Waddell, Nicola, Easton, Douglas F., Dunning, Alison M., Chenevix-Trench, Georgia, Edwards, Stacey L. and French, Juliet D. (2020). Non-coding RNAs underlie genetic predisposition to breast cancer. Genome Biology, 21 (1) 7, 7. doi: 10.1186/s13059-019-1876-z

Non-coding RNAs underlie genetic predisposition to breast cancer

2020

Journal Article

The path to a better biomarker: Application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice

Gonzalez-Ericsson, Paula I., Stovgaard, Elisabeth S., Sua, Luz F., Reisenbichler, Emily, Kos, Zuzana, Carter, Jodi M., Michiels, Stefan, Le Quesne, John, Nielsen, Torsten O., Lænkholm, Anne-Vibeke, Fox, Stephen B., Adam, Julien, Bartlett, John M.S., Rimm, David L., Quinn, Cecily, Peeters, Dieter, Dieci, Maria V., Vincent-Salomon, Anne, Cree, Ian, Hida, Akira I., Balko, Justin M., Haynes, Harry R., Frahm, Isabel, Acosta-Haab, Gabriela, Balancin, Marcelo, Bellolio, Enrique, Yang, Wentao, Kirtani, Pawan, Sugie, Tomoharu ... Sanders, Melinda (2020). The path to a better biomarker: Application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice. Journal of Pathology, 250 (5), 667-684. doi: 10.1002/path.5406

The path to a better biomarker: Application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice

2020

Journal Article

Survival and disease characteristics of de novo versus recurrent metastatic breast cancer in a cohort of young patients

McKenzie, Hayley S., Maishman, Tom, Simmonds, Peter, Durcan, Lorraine, Altman, Douglas G., Jones, Louise, Evans, Gareth, Thompson, Alastair M., Pharaoh, Paul, Hanby, Andrew, Lakhani, Sunil, Eeles, Ros, Gilbert, Fiona J., Hamed, Hisham, Hodgson, Shirley, Simmonds, Peter, Eccles, Diana, Eccles, Diana, Copson, Ellen and POSH Steering Group (2020). Survival and disease characteristics of de novo versus recurrent metastatic breast cancer in a cohort of young patients. British Journal of Cancer, 122 (11), 1618-1629. doi: 10.1038/s41416-020-0784-z

Survival and disease characteristics of de novo versus recurrent metastatic breast cancer in a cohort of young patients

2019

Journal Article

Publisher Correction: Homologous recombination DNA repair defects in PALB2-associated breast cancers (npj Breast Cancer, (2019), 5, 1, (23), 10.1038/s41523-019-0115-9)

Li, Anqi, Geyer, Felipe C., Blecua, Pedro, Lee, Ju Youn, Selenica, Pier, Brown, David N., Pareja, Fresia, Lee, Simon S. K., Kumar, Rahul, Rivera, Barbara, Bi, Rui, Piscuoglio, Salvatore, Wen, Hannah Y., Lozada, John R., Gularte-Mérida, Rodrigo, Cavallone, Luca, Aghmesheh, Morteza, Amor, David, Andrews, Leslie, Antill, Yoland, Balleine, Rosemary, Beesley, Jonathan, Blackburn, Anneke, Bogwitz, Michael, Brown, Melissa, Burgess, Matthew, Burke, Jo, Butow, Phyllis, Caldon, Liz ... Reis-Filho, Jorge S. (2019). Publisher Correction: Homologous recombination DNA repair defects in PALB2-associated breast cancers (npj Breast Cancer, (2019), 5, 1, (23), 10.1038/s41523-019-0115-9). npj Breast Cancer, 5 (1) 44. doi: 10.1038/s41523-019-0140-8

Publisher Correction: Homologous recombination DNA repair defects in PALB2-associated breast cancers (npj Breast Cancer, (2019), 5, 1, (23), 10.1038/s41523-019-0115-9)

2019

Journal Article

Development and validation of a targeted gene sequencing panel for application to disparate cancers

McCabe, Mark J., Gauthier, Marie-Emilie A., Chan, Chia-Ling, Thompson, Tanya J., De Sousa, Sunita M.C., Puttick, Clare, Grady, John P., Gayevskiy, Velimir, Tao, Jiang, Ying, Kevin, Cipponi, Arcadi, Deng, Niantao, Swarbrick, Alex, Thomas, Melissa L., Lord, Reginald V., Johns, Amber L., Kohonen-Corish, Maija, O’Toole, Sandra A., Clark, Jonathan, Mueller, Simon A., Gupta, Ruta, McCormack, Ann I., Dinger, Marcel E., Cowley, Mark J., Aghmesheh, Morteza, Amor, David, Andrews, Lesley, Antill, Yoland, Armitage, Shane ... Young, Mary-Anne (2019). Development and validation of a targeted gene sequencing panel for application to disparate cancers. Scientific Reports, 9 (1) 17052, 17052. doi: 10.1038/s41598-019-52000-3

Development and validation of a targeted gene sequencing panel for application to disparate cancers

2019

Journal Article

LobSig is a multigene predictor of outcome in invasive lobular carcinoma

McCart Reed, Amy E., Lal, Samir, Kutasovic, Jamie R., Wockner, Leesa, Robertson, Alan, de Luca, Xavier M., Kalita-de Croft, Priyakshi, Dalley, Andrew J., Coorey, Craig P., Kuo, Luyu, Ferguson, Kaltin, Niland, Colleen, Miller, Gregory, Johnson, Julie, Reid, Lynne E., Males, Renique, Saunus, Jodi M., Chenevix-Trench, Georgia, Coin, Lachlan, Lakhani, Sunil R. and Simpson, Peter T. (2019). LobSig is a multigene predictor of outcome in invasive lobular carcinoma. npj Breast Cancer, 5 (1) 18, 18. doi: 10.1038/s41523-019-0113-y

LobSig is a multigene predictor of outcome in invasive lobular carcinoma

2019

Journal Article

Correction: DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer (Oncogene, (2017), 36, 33, (4802-4809), 10.1038/onc.2017.21)

Hernández-Pérez, S., Cabrera, E., Salido, E., Lim, M., Reid, L., Lakhani, S. R., Khanna, K. K., Saunus, J. M. and Freire, R. (2019). Correction: DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer (Oncogene, (2017), 36, 33, (4802-4809), 10.1038/onc.2017.21). Oncogene, 38 (24), 4886-4886. doi: 10.1038/s41388-019-0753-2

Correction: DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer (Oncogene, (2017), 36, 33, (4802-4809), 10.1038/onc.2017.21)